CROI 2016 Program at a Glance

Program and Agenda

10:15 42 Comparing Cardiovascular Disease Risk Scores for Use in HIV-Infected Individuals Heidi M. Crane 1 ; Robin Nance 1 ; Joseph A. Delaney 2 ; Daniel Drozd 1 ; Susan Heckbert 1 ; RebekahYoung 1 ; Matthew J. Feinstein 3 ; Richard Moore 4 ; Michael S. Saag 5 ; Mari Kitahata 1 1 UnivofWashington,Seattle,WA,USA; 2 UnivofWashingtonSch ofPH,Seattle,WA,USA; 3 NorthwesternUniv,FeinbergSchofMed, Chicago, IL,USA; 4 JohnsHopkinsUniv,Baltimore,MD,USA; 5 Univ ofAlabamaatBirmingham,Birmingham,AL,USA 10:30 43 Stroke Incidence Highest inWomen and Black

11:30 47 A Single Dose Zoledronic Acid Prevents Antiretroviral-Induced Bone Loss

Ighovwerha Ofotokun 1 ; KehmiaTitanji 1 ; AswaniVunnava 1 ; Antonina Foster 1 ; Anandi N. Sheth 1 ; Cecile D. Lahiri 1 ; Jeffrey L. Lennox 1 ; Andrea Knezevic 2 ; Kirk A. Easley 2 ; M. N.Weitzmann 1 1 EmoryUnivSchofMed,Atlanta,GA,USA; 2 EmoryUnivRollins SchofPH,Atlanta,GA,USA 11:45 48LB Recovery of Bone Mineral Density After Stopping Oral HIV Preexposure Prophylaxis

Robert Grant 1 ; Kathleen Mulligan 1 ;Vanessa McMahan 2 ; AlbertY. Liu 3 ; Juan Guanira 4 ; Suwat Chariyalertsak 5 ; Linda-Gail Bekker 6 ; Mauro Schechter 7 ;Valdilea G.Veloso 8 ; DavidV. Glidden 1 ; for the iPrEx study team. 1 UnivofCaliforniaSanFrancisco,SanFrancisco,CA,USA; 2 Gladstone Insts,SanFrancisco,CA,USA; 3 SanFranciscoDeptof PH,SanFrancisco,CA,USA; 4 InvestigacionesMédicasenSalud, Lima,Peru; 5 UnivofChiangMai,ChiangMai,Thailand; 6 Desmond TutuHIVCntr,CapeTown,SouthAfrica; 7 ProjetoPraçaOnze, UniversidadeFeddoRiode Janeiro,Riode Janeiro,Brazil; 8 Fiocruz, Riode Janeiro,Brazil

HIV-Infected Participants in ALLRT Cohort Felicia Chow 1 ; Michael R.Wilson 1 ; KunlingWu 2 ; Ron Ellis 3 ; Ronald Bosch 2 ; Benjamin P. Linas 4

1 UnivofCaliforniaSanFrancisco,SanFrancisco,CA,USA; 2 Harvard SchofPH,Boston,MA,USA; 3 UnivofCaliforniaSanDiego,San Diego,CA,USA; 4 BostonUnivSchofMed,Boston,MA,USA 10:45 44LB Aspirin Fails to Impact Immune Activation or Endothelial Function in Treated HIV

Tuesday, February 23, 2016 • Oral Sessions

Meagan K. O’Brien 1 ; Douglas Kitch 2 ; PeterW. Hunt 3 ; Karin Klingman 4 ; James H. Stein 5 ; NicholasT. Funderburg 6 ; Jeffrey S. Berger 7 ; PabloTebas 8 ; Judith Aberg 1 ; for the ACTG A5331 Study Team

Session O-5 Oral Abstracts

Ballroom A

10:00 AM-12:00 PM Strategies for Testing and Linkage to Care: AreWe Closing the Gap? Oral Abstract Moderators Demetre C. Daskalakis, NewYorkCityDepartmentofHealthandMental Hygiene,Queens,NY,USA Heidi van Rooyen, HumanSciencesResearchCouncil,Durban,SouthAfrica 10:00 49 Male Partner Home HIV Testing vs Clinic

1 IcahnSchofMedatMountSinai,NewYork,NY,USA; 2 Harvard SchofPH,Boston,MA,USA; 3 UnivofCaliforniaSanFrancisco, SanFrancisco,CA,USA; 4 NIAID,NIH,Bethesda,MD,USA; 5 Univ ofWisconsin-Madison,Madison,WI,USA; 6 OhioStateUniv, Columbus,OH,USA; 7 NewYorkUnivSchoolofMed,NewYork,NY, USA; 8 UnivofPennsylvania,Philadelphia,PA,USA 11:00 45 Body Composition Changes on DRV/r + Either RAL or TDF/FTC As First-Line ART 1 Inst forHlthRsrofLaPazUnivHosp,Madrid,Spain; 2 UnivColl London,London,UK; 3 INSERMU897,UnivdeBordeaux,Bordeaux, France; 4 HopitalSaint-Louis,Paris,France; 5 HospdelMar Barcelona,Barcelona,Spain; 6 UnivHospMontpellier,Montpellier, France; 7 UnivHospNantes,Nantes,France 11:15 46 Antiretrovirals, Fractures, and Osteonecrosis in a Large European HIV Cohort Alvaro H. Borges 1 ; Jennifer Hoy 2 ; Eric Florence 3 ; Dalibor Jose I. Bernardino 1 ; Amanda Mocroft 2 ; CedrickWallet 3 ; Jean- Michel Molina 4 ; Hernando Knobell 5 ; Jacques Reynes 6 ; Abdel Babiker 2 ; François Raffi 7 ; Jose R. Arribas 1 ; for the NEAT 001/ ANRS 143 Study group

Invitation in Pregnancy: A Randomized Trial Daisy Krakowiak 1 ; John Kinuthia 2 ; Alfred Osoti 2 ;Victor Asila 3 ; Molly Ann Gone 3 ; Jennifer Mark 1 ; Monisha Sharma 1 ; RuanneV. Barnabas 1 ; Carey Farquhar 1 1 UnivofWashington,Seattle,WA,USA; 2 KenyattaNatlHosp, Nairobi,Kenya; 3 UnivofNairobi,Nairobi,Kenya

10:15 50 Effectiveness of Partner Services for HIV in Kenya: A Cluster Randomized Trial

Peter Cherutich 1 ; Mathew R. Golden 2 ; BeatriceWamuti 3 ; Barbra A. Richardson 1 ; Kristjana H. Ásbjörnsdóttir 1 ; Felix A. Otieno 3 ; Betsy Sambai 3 ; Matt Dunbar 1 ; Carey Farquhar 1 ; for the aPS Study Group

Sedlacek 4 ; Hans-Jürgen Stellbrink 5 ;Vilma Uzdaviniene 6 ;Tomazic Janez 7 ; Panagiotis Gargalianos-Kakolyris 8 ; Jens D. Lundgren 9 ; Amanda Mocroft 10 ; for the for EuroSIDA in EuroCOORD 1 CHIP,RigsHospet,UnivofCopenhagen,Copenhagen,Denmark; 2 AlfredHosp,Melbourne,Australia; 3 InstofTropMedAntwerp, Antwerp,Belgium; 4 CharlesUnivHospPlzen,Plzen,Czech Republic; 5 ICHStudyCntr,Hamburg,Germany; 6 VilniusUnivHosp SantariskiuKlinikos,Vilnius,Lithuania; 7 UnivMedCntrLjubljana, Ljubljana,Slovenia; 8 GeneralHospofAthens "G.Gennimatas", Athens,Greece; 9 RigsHospet,UnivofCopenhagen,Copenhagen, Denmark; 10 UnivCollLondon,London,UK

1 UnivofWashington,Seattle,WA,USA; 2 UnivofWashingtonSch ofMed,Seattle,WA,USA; 3 KenyattaNatlHosp,Nairobi,Kenya 10:30 51 Optimal Timing of Home-Based HIV Testing in Western Kenya Jack J. Olney 1 ; Paula Braitstein 2 ; JeffreyW. Eaton 1 ; Edwin Sang 3 ; Monicah Nyambura 3 ; Sylvester Kimaiyo 4 ; Ellen McRobie 1 ; Joseph Hogan 5 ;Timothy Hallett 1

1 ImperialCollLondon,London,UK; 2 UnivofToronto,Toronto,ON, Canada; 3 AcademicModelProvidingAccess toHlthcare,Eldoret, Kenya; 4 MoiUniv,Eldoret,Kenya; 5 BrownUniv,Providence,RI, USA

27

CROI 2016